Janet Woodcock (Greg Nash/Pool via AP)

FDA+ roundup: Janet Wood­cock de­fends her 'most' will get Covid com­ment, talks short­ages and gov­ern­ment trust

Janet Wood­cock’s tenure as act­ing FDA com­mis­sion­er may soon come to an end (pend­ing Rob Califf’s con­fir­ma­tion), but that doesn’t mean she has to leave the FDA, and her im­mi­nent de­par­ture as com­mish hasn’t slowed her down from car­ry­ing on, with speech­es to at least three dif­fer­ent con­fer­ences so far this month, and tes­ti­mo­ny be­fore a Sen­ate health com­mit­tee.

In that tes­ti­mo­ny, Wood­cock’s com­ments sent re­ver­ber­a­tions across the US, blunt­ly telling the coun­try, “Most peo­ple are go­ing to get Covid.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.